Tissue drug concentrations of anti-tumor necrosis factor agents are associated with the long-term outcome of patients with Crohn's disease

T Yoshihara, S Shinzaki, S Kawai, H Fujii… - Inflammatory bowel …, 2017 - academic.oup.com
Background: Many reports indicate that a high-serum trough level of anti-tumor necrosis
factor (TNF) agents is required for sustained remission in patients with Crohn's disease The …
被引用次数：24 相关文章

Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohn's Disease

T Yoshihara, S Shinzaki, S Kawai… - Inflammatory …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Many reports indicate that a high-serum trough level of anti-tumor necrosis
factor (TNF) agents is required for sustained remission in patients with Crohn's disease The …

Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohn's Disease.

T Yoshihara, S Shinzaki, S Kawai, H Fujii… - Inflammatory Bowel …, 2017 - europepmc.org
Background Many reports indicate that a high-serum trough level of anti-tumor necrosis
factor (TNF) agents is required for sustained remission in patients with Crohn's disease The …

[引用][C] Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohnʼs Disease

T Yoshihara, S Shinzaki, S Kawai, H Fujii… - Inflammatory Bowel …, 2017 - cir.nii.ac.jp
Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the
Long-term Outcome of Patients with Crohnʼs Disease | CiNii Research CiNii 国立情報学研究所 …